Delcath Systems to Hold Investor Update on Focus Trial Data and Future Development Plans on December 2, 2021
05 nov. 2021 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,...
Delcath Systems Schedules Conference Call to Report 2021 Third Quarter Financial Results
25 oct. 2021 16h01 HE
|
Delcath Systems, Inc.
NEW YORK, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Present at Upcoming Virtual Investor Conferences
02 sept. 2021 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,...
Delcath Systems Announces Second Quarter 2021 Results
10 août 2021 07h30 HE
|
Delcath Systems, Inc.
NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Secures Up to a $20.0 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
09 août 2021 07h30 HE
|
Delcath Systems, Inc.
NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Present at Upcoming Virtual Investor Conferences
05 août 2021 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial Results
28 juil. 2021 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, July 28, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Present at Access to Giving Virtual Conference on July 13, 2021 at 3 p.m. ET
07 juil. 2021 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Set to Join Russell Microcap® Index
08 juin 2021 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, is...
Positive Preliminary Results from Delcath Systems’ FOCUS Trial Presented at the 2021 ASCO Annual Meeting
07 juin 2021 07h30 HE
|
Delcath Systems, Inc.
As Previously Disclosed, the Prespecified Primary Endpoint, Objective Response Rate, Has Been Met by Exceeding the 95% CI Lower Bound Threshold for Success Newly Disclosed Patient Level Data...